Summary of Significant Accounting Policies (Details) - Schedule of Potential Common Stock Equivalents Outstanding - shares	9 Months Ended
Sep. 30, 2024	Sep. 30, 2023
Schedule of Potential Common Stock Equivalents Outstanding [Line Items]
Potential common stock equivalents outstanding	2,486,744	461,329
Stock Option [Member]
Schedule of Potential Common Stock Equivalents Outstanding [Line Items]
Potential common stock equivalents outstanding	298,919	213,113
Warrants [Member]
Schedule of Potential Common Stock Equivalents Outstanding [Line Items]
Potential common stock equivalents outstanding	2,187,825	248,216

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration